Apimeds Pharmaceuticals US Growth Metrics (2024-2025) | APUS

Growth Metrics Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) -96.91%1,257,338.43%
Assets (QoQ) (Quarter) 1,890.53%3,957.91%-12.29%1,674.95%
Capital Expenditures (QoQ) (Quarter) -4.95%
Cash & Equivalents Growth (1y) (Quarter) -99.16%47,270.62%
Cash & Equivalents (QoQ) (Quarter) 7,145.79%3,389.36%-20.02%-76.57%
Cash from Investing Activities (QoQ) (Quarter) -44,374.01%
Cash from Operations Growth (1y) (Quarter) 92.28%-1,726.14%-824.29%-3,732.92%
Cash from Operations (QoQ) (Quarter) 30.04%-1.47%46.66%79.61%-16,446.53%48.64%-121.20%
EBIT Growth (1y) (Quarter) -34.09%-522.76%-514.75%-2,454.32%
EBIT (QoQ) (Quarter) -57.42%29.87%8.13%-32.20%-631.10%30.77%-281.73%
EBT Growth (1y) (Quarter) -35.73%-494.56%-439.55%-2,216.75%
EBT (QoQ) (Quarter) -51.57%26.00%6.28%-29.13%-563.95%32.85%-302.41%
Enterprise Value Growth (1y) (Quarter) 99.16%-105,157.74%
Enterprise Value (QoQ) (Quarter) -7,145.79%-3,389.36%20.02%47.95%
EPS (Basic) Growth (1y) (Quarter) -25.00%-333.33%-250.00%-100.00%
EPS (Basic) (QoQ) (Quarter) -50.00%33.33%0.00%-25.00%-420.00%46.15%42.86%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) -25.00%-333.33%-250.00%-100.00%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) -50.00%33.33%0.00%-25.00%-420.00%46.15%42.86%
Free Cash Flow Growth (1y) (Quarter) 92.28%-1,726.14%-836.36%-3,754.43%
Free Cash Flow (QoQ) (Quarter) 30.04%-1.47%46.66%79.61%-16,446.53%47.97%-119.57%
Interest Coverage Ratio Growth (1y) (Quarter) 5.13%-497.61%-3,084.28%-327.06%
Interest Coverage Ratio (QoQ) (Quarter) -91.47%52.46%16.82%-25.31%-1,106.09%-153.30%88.84%
Net Cash Flow Growth (1y) (Quarter) 193.84%4,717.29%-4,657.74%-23,043.98%
Net Cash Flow (QoQ) (Quarter) 30.04%80.03%37.11%1,168.04%3,342.20%-120.58%-205.94%
Net Income Growth (1y) (Quarter) -35.73%-494.56%-439.55%-2,216.75%
Net Income (QoQ) (Quarter) -51.57%26.00%6.28%-29.13%-563.95%32.85%-302.41%
Net Income towards Common Stockholders Growth (1y) (Quarter) -35.73%-494.56%-439.55%-2,216.75%
Net Income towards Common Stockholders (QoQ) (Quarter) -51.57%26.00%6.28%-29.13%-563.95%32.85%-302.41%
Operating Income Growth (1y) (Quarter) -34.09%-522.76%-514.75%-2,454.32%
Operating Income (QoQ) (Quarter) -57.42%29.87%8.13%-32.20%-631.10%30.77%-281.73%
Profit After Tax Growth (1y) (Quarter) -35.73%-492.44%-435.68%-270.72%
Profit After Tax (QoQ) (Quarter) -51.57%26.00%6.28%-29.13%-561.58%33.09%35.14%
Property, Plant & Equipment (Net) (QoQ) (Quarter) 160.24%51.01%
Return on Assets (QoQ) (Quarter) 10.000.000.00
Return on Capital Employed (QoQ) (Quarter) -16215.002,000.004,277.00
Return on Equity Growth (1y) (Quarter) -2.00-1.00
Return on Equity (QoQ) (Quarter) 0.000.00-2.000.000.00
Share-based Compensation (QoQ) (Quarter) -76.08%4,140.19%
Shareholder's Equity Growth (1y) (Quarter) -4,361.57%-565.34%1,463.88%879.81%11,391.18%
Shareholder's Equity (QoQ) (Quarter) -930.29%-169.82%-46.57%-29.78%-29.63%653.11%-16.20%1,779.11%